As of Jul 31
| +0.0199 / +1.27%|
The 1 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +57.23% increase from the last price of 1.59.
The current consensus among 1 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.